$SCPX
Scorpius Holdings, Inc.

2022 Q4 Form 10-Q Financial Statement

#000155837022017784 Filed on November 14, 2022

View on sec.gov

Income Statement

Concept 2022 Q4 2022 Q3
Revenue $79.92K $6.040M
YoY Change -86.96% 1104.2%
Cost Of Revenue $38.24K $6.363M
YoY Change
Gross Profit $41.68K -$322.9K
YoY Change
Gross Profit Margin 52.15% -5.35%
Selling, General & Admin $7.350M $5.114M
YoY Change 26.34% 50.86%
% of Gross Profit 17633.23%
Research & Development $7.940M $6.861M
YoY Change 16.47% 56.6%
% of Gross Profit 19050.07%
Depreciation & Amortization $1.490M $442.5K
YoY Change 674.45% 283.94%
% of Gross Profit 3574.98%
Operating Expenses $15.54M $6.861M
YoY Change 22.79% -14.94%
Operating Profit -$15.50M -$13.00M
YoY Change 71.8%
Interest Expense $325.8K $97.55K
YoY Change 21.57% -51.75%
% of Operating Profit
Other Income/Expense, Net -$210.3K -$313.8K
YoY Change -59.95% -1962.87%
Pretax Income -$15.39M -$13.31M
YoY Change 11.86% 76.34%
Income Tax -$3.073M -$215.9K
% Of Pretax Income
Net Earnings -$12.15M -$13.01M
YoY Change -10.41% 74.97%
Net Earnings / Revenue -15204.55% -215.33%
Basic Earnings Per Share -$0.51
Diluted Earnings Per Share -$0.47 -$0.51
COMMON SHARES
Basic Shares Outstanding 25.66M 25.66M
Diluted Shares Outstanding 25.61M

Balance Sheet

Concept 2022 Q4 2022 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $44.27M $57.45M
YoY Change -54.06% -47.25%
Cash & Equivalents $8.435M $13.66M
Short-Term Investments $35.84M $43.79M
Other Short-Term Assets $3.576M $2.430M
YoY Change 23.87% -14.58%
Inventory
Prepaid Expenses
Receivables $81.46K $5.908M
Other Receivables $2.125M $688.1K
Total Short-Term Assets $50.05M $66.47M
YoY Change -49.61% -40.56%
LONG-TERM ASSETS
Property, Plant & Equipment $20.48M $20.73M
YoY Change 848.83% 1073.27%
Goodwill $3.302M $3.468M
YoY Change 138.77%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $556.7K $265.2K
YoY Change -97.14% -98.61%
Total Long-Term Assets $54.34M $53.69M
YoY Change 151.24% 157.83%
TOTAL ASSETS
Total Short-Term Assets $50.05M $66.47M
Total Long-Term Assets $54.34M $53.69M
Total Assets $104.4M $120.2M
YoY Change -13.69% -9.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.424M $3.479M
YoY Change 379.43% 226.48%
Accrued Expenses $4.302M $3.823M
YoY Change 77.79% 130.27%
Deferred Revenue $1.586M
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $301.1K $329.0K
YoY Change 15.54% 47.97%
Total Short-Term Liabilities $18.04M $14.45M
YoY Change 282.09% 339.19%
LONG-TERM LIABILITIES
Long-Term Debt $5.520M $6.538M
YoY Change 2061.07% 1778.03%
Other Long-Term Liabilities $8.403M $12.72M
YoY Change 15597.53% 25091.86%
Total Long-Term Liabilities $13.92M $19.26M
YoY Change 25909.56% 38035.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $18.04M $14.45M
Total Long-Term Liabilities $13.92M $19.26M
Total Liabilities $31.96M $37.04M
YoY Change 257.99% 321.39%
SHAREHOLDERS EQUITY
Retained Earnings -$209.2M -$197.0M
YoY Change 26.24% 29.43%
Common Stock $5.126K $5.122K
YoY Change 1.4% 1.87%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $73.92M $84.47M
YoY Change
Total Liabilities & Shareholders Equity $104.4M $120.2M
YoY Change -13.69% -9.42%

Cashflow Statement

Concept 2022 Q4 2022 Q3
OPERATING ACTIVITIES
Net Income -$12.15M -$13.01M
YoY Change -10.41% 74.97%
Depreciation, Depletion And Amortization $1.490M $442.5K
YoY Change 674.45% 283.94%
Cash From Operating Activities -$7.842M $3.571M
YoY Change -31.15% -122.69%
INVESTING ACTIVITIES
Capital Expenditures $846.9K -$15.92M
YoY Change -262.52% -803.21%
Acquisitions
YoY Change
Other Investing Activities $8.216M $15.77M
YoY Change -32.34% -11125.56%
Cash From Investing Activities $7.369M -$148.4K
YoY Change -36.59% -107.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -4.761M -34.52K
YoY Change 7640.64% -43.56%
NET CHANGE
Cash From Operating Activities -7.842M 3.571M
Cash From Investing Activities 7.369M -148.4K
Cash From Financing Activities -4.761M -34.52K
Net Change In Cash -5.234M 3.388M
YoY Change -3172.65% -124.77%
FREE CASH FLOW
Cash From Operating Activities -$7.842M $3.571M
Capital Expenditures $846.9K -$15.92M
Free Cash Flow -$8.689M $19.49M
YoY Change -20.05% -208.28%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24828438
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25613316
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25137628
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25603481
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25613316
CY2021Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25137628
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
25603481
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24828438
dei Entity Central Index Key
EntityCentralIndexKey
0001476963
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Amendment Flag
AmendmentFlag
false
CY2022Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.05
CY2021Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.94
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
-0.83
us-gaap Business Acquisition Pro Forma Earnings Per Share Diluted
BusinessAcquisitionProFormaEarningsPerShareDiluted
0.28
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25649824
CY2022Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25614629
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.51
CY2021Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.30
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-1.22
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-09-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-35994
dei Entity Registrant Name
EntityRegistrantName
NightHawk Biosciences, Inc.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
26-2844103
dei Entity Address Address Line1
EntityAddressAddressLine1
627 Davis Drive, Suite 400
dei Entity Address City Or Town
EntityAddressCityOrTown
Morrisville
dei Entity Address State Or Province
EntityAddressStateOrProvince
NC
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
27560
dei City Area Code
CityAreaCode
919
dei Local Phone Number
LocalPhoneNumber
240-7133
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
NHWK
dei Security Exchange Name
SecurityExchangeName
NYSEAMER
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
25661488
CY2021Q4 us-gaap Short Term Investments
ShortTermInvestments
88324922
CY2022Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13658242
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8053879
CY2022Q3 us-gaap Short Term Investments
ShortTermInvestments
43789736
CY2022Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
5907829
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
66049
CY2022Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
688089
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2430493
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2886520
CY2022Q3 us-gaap Assets Current
AssetsCurrent
66474389
CY2021Q4 us-gaap Assets Current
AssetsCurrent
99331370
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20730517
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158479
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
9033125
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3500000
CY2022Q3 us-gaap Goodwill
Goodwill
3467748
CY2022Q3 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1524522
CY2021Q4 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1318359
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
2023943
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1782884
CY2022Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
16645455
CY2021Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
470700
CY2021Q4 us-gaap Other Assets Miscellaneous Noncurrent
OtherAssetsMiscellaneousNoncurrent
12193540
CY2022Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
265215
CY2021Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
205901
CY2022Q3 us-gaap Assets
Assets
120164914
CY2021Q4 us-gaap Assets
Assets
120961233
CY2022Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
3479175
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
922782
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
550128
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
350343
CY2022Q3 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
328959
CY2021Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
260574
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3823173
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2419676
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
6269114
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
593037
CY2021Q4 nhwk Business Combination Contingent Consideration Liability Related Party Current
BusinessCombinationContingentConsiderationLiabilityRelatedPartyCurrent
174333
CY2022Q3 us-gaap Liabilities Current
LiabilitiesCurrent
14450549
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4720745
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
53530
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
274
CY2021Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
11020
CY2022Q3 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3326000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
215937
CY2022Q3 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
751350
CY2021Q4 us-gaap Contract With Customer Liability Noncurrent
ContractWithCustomerLiabilityNoncurrent
35000
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1173040
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
1060856
CY2022Q3 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
6537975
CY2021Q4 us-gaap Finance Lease Liability Noncurrent
FinanceLeaseLiabilityNoncurrent
255429
CY2022Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
10800000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
1990118
CY2021Q4 nhwk Business Combination Contingent Consideration Liability Related Party Noncurrent
BusinessCombinationContingentConsiderationLiabilityRelatedPartyNoncurrent
585027
CY2022Q3 us-gaap Liabilities
Liabilities
37039188
CY2021Q4 us-gaap Liabilities
Liabilities
8927662
CY2022Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0002
CY2022Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
250000000
CY2022Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
25614629
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
25649824
CY2022Q3 us-gaap Common Stock Value
CommonStockValue
5122
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
5055
CY2022Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
281320475
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
278890153
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197002176
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-165718953
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
142304
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-67941
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
84465725
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
113108314
CY2022Q3 us-gaap Minority Interest
MinorityInterest
-1339999
CY2021Q4 us-gaap Minority Interest
MinorityInterest
-1074743
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
83125726
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112033571
CY2022Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120164914
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
120961233
CY2022Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6039853
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
501567
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
6303252
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1499706
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6362783
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
6362783
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6861470
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
4381542
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15521334
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
12004084
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5114185
CY2021Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3390093
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
13781352
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
11011003
CY2022Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
316875
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
666875
CY2022Q3 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3500000
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3500000
CY2022Q3 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3118515
CY2021Q3 nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
295000
nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3342515
nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
406000
CY2022Q3 us-gaap Costs And Expenses
CostsAndExpenses
19036798
CY2021Q3 us-gaap Costs And Expenses
CostsAndExpenses
8066635
us-gaap Costs And Expenses
CostsAndExpenses
36489829
us-gaap Costs And Expenses
CostsAndExpenses
23421087
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-12996945
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7565068
us-gaap Operating Income Loss
OperatingIncomeLoss
-30186577
us-gaap Operating Income Loss
OperatingIncomeLoss
-21921381
CY2022Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1456
CY2021Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-6831
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10746
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2808
CY2022Q3 us-gaap Interest Income Other
InterestIncomeOther
241638
CY2021Q3 us-gaap Interest Income Other
InterestIncomeOther
195344
us-gaap Interest Income Other
InterestIncomeOther
537513
us-gaap Interest Income Other
InterestIncomeOther
567307
CY2022Q3 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-145543
us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
-1577174
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-411314
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-185332
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-548924
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-440675
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-313763
CY2021Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
16843
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1577839
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129440
CY2022Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13310708
CY2021Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-7548225
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-31764416
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-21791941
CY2022Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-215937
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-215937
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13094771
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7548225
us-gaap Profit Loss
ProfitLoss
-31548479
us-gaap Profit Loss
ProfitLoss
-21791941
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-89421
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-115505
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-265256
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-283846
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13005350
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7432720
us-gaap Net Income Loss
NetIncomeLoss
-31283223
us-gaap Net Income Loss
NetIncomeLoss
-21508095
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25613316
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25137628
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25603481
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24828438
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13094771
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7548225
us-gaap Profit Loss
ProfitLoss
-31548479
us-gaap Profit Loss
ProfitLoss
-21791941
CY2022Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
115659
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
68582
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
210245
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
113511
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-12979112
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7479643
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-31338234
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-21678430
CY2022Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-89421
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-115505
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-265256
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-283846
CY2022Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-12889691
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7364138
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-31072978
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-21394584
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
95387663
CY2022Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
717175
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
115659
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13094771
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
83125726
CY2021Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
112033571
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
2430389
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
210245
us-gaap Profit Loss
ProfitLoss
-31548479
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
83125726
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
130472343
CY2021Q3 us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
872740
CY2021Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
68582
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7548225
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
123865440
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
115493923
nhwk Stock Issued During Period Value New Issues2
StockIssuedDuringPeriodValueNewIssues2
26304282
us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
658184
us-gaap Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
4376588
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
27261
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
113511
us-gaap Profit Loss
ProfitLoss
-21791941
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
123865440
us-gaap Profit Loss
ProfitLoss
-31548479
us-gaap Profit Loss
ProfitLoss
-21791941
us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
3500000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
988715
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
415270
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
666875
nhwk Noncash Lease Expense
NoncashLeaseExpense
127681
nhwk Noncash Lease Expense
NoncashLeaseExpense
78697
us-gaap Share Based Compensation
ShareBasedCompensation
2430389
us-gaap Share Based Compensation
ShareBasedCompensation
4376588
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-10746
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2808
nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
-3342515
nhwk Change In Fair Value Of Contingent Consideration
ChangeInFairValueOfContingentConsideration
406000
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-1577174
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-278172
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
5843564
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-104598
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1210730
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1029581
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-24526231
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-443968
nhwk Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
206163
nhwk Increase Decrease In Grants Receivable
IncreaseDecreaseInGrantsReceivable
870032
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-5844000
nhwk Increase Decrease In Other Assets Miscellaneous Noncurrent
IncreaseDecreaseInOtherAssetsMiscellaneousNoncurrent
-12493539
nhwk Increase Decrease In Other Assets Miscellaneous Noncurrent
IncreaseDecreaseInOtherAssetsMiscellaneousNoncurrent
8199850
nhwk Increase Decrease In Operating Lease Right Of Use Assets
IncreaseDecreaseInOperatingLeaseRightOfUseAssets
9974366
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
2354279
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
14766
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-3512090
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
197428
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-53530
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
14268
us-gaap Increase Decrease In Other Deferred Liability
IncreaseDecreaseInOtherDeferredLiability
-215937
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
718850
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-603717
nhwk Increase Decrease In Deposits Operating Activity
IncreaseDecreaseInDepositsOperatingActivity
-33064
nhwk Increase Decrease In Deposits Operating Activity
IncreaseDecreaseInDepositsOperatingActivity
-126778
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2141977
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-26738920
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
1989767
us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
66665908
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
44947779
us-gaap Proceeds From Sale Maturity And Collection Of Shortterm Investments
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
66197924
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19271087
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1383596
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
-2719898
us-gaap Payment For Contingent Consideration Liability Investing Activities
PaymentForContingentConsiderationLiabilityInvestingActivities
22784571
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
3622252
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1851580
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
26304282
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
27261
us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
658184
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
145672
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
121503
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-145672
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
25551856
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-14194
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-10834
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
5604363
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-3049478
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8053879
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
10931890
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
13658242
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7882412
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
351098
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
88596
nhwk Right Of Use Asset Obtained In Exchange For Operating Lease Liability Modifications
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityModifications
37767
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
16470969
us-gaap Right Of Use Asset Obtained In Exchange For Finance Lease Liability
RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
408677
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
1233232
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
42853685
CY2022Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-197000000.0
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13100000
us-gaap Profit Loss
ProfitLoss
-31500000
CY2022Q3 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
57400000
CY2022Q3 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
274
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:'Times New Roman','Times','serif';font-size:10pt;font-style:italic;font-weight:bold;margin:0pt 0pt 12pt 0pt;">Use of Estimates</p><p style="font-family:'Times New Roman','Times','serif';font-size:10pt;text-align:justify;margin:0pt 0pt 12pt 0pt;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Estimates are used for, but not limited to, useful lives of fixed assets, contingent consideration, in process research and development (“IPR&amp;D”), income taxes, valuation of warrant liabilities, and stock-based compensation. Actual results may differ from those estimates.</p>
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
40000.00
CY2022Q3 nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
40000.00
CY2021Q3 nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
0.0
nhwk Amount Of Allowable Expenses Incurred Under Grant
AmountOfAllowableExpensesIncurredUnderGrant
30000.00
CY2022Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
29347513
CY2021Q3 us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
44237698
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
29892585
us-gaap Business Acquisitions Pro Forma Revenue
BusinessAcquisitionsProFormaRevenue
46834404
CY2022Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-1296510
CY2021Q3 us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
23542744
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
-21282125
us-gaap Business Acquisitions Pro Forma Net Income Loss
BusinessAcquisitionsProFormaNetIncomeLoss
7072846
CY2022Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.05
CY2021Q3 us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.94
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
-0.83
us-gaap Business Acquisition Pro Forma Earnings Per Share Basic
BusinessAcquisitionProFormaEarningsPerShareBasic
0.28
CY2021Q3 nhwk Assets Transfer From Level1 To Level2 Transfers Amount1
AssetsTransferFromLevel1ToLevel2TransfersAmount1
0
CY2022Q3 nhwk Assets Transfer From Level1 To Level2 Transfers Amount1
AssetsTransferFromLevel1ToLevel2TransfersAmount1
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet
0
CY2021Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q3 us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Transfers Net
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet
0
CY2022Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
9357
CY2022Q3 nhwk Prepaid Preclinical And Clinical Expenses
PrepaidPreclinicalAndClinicalExpenses
1097594
CY2021Q4 nhwk Prepaid Preclinical And Clinical Expenses
PrepaidPreclinicalAndClinicalExpenses
1158560
CY2022Q3 nhwk Prepaid Manufacturing Expense
PrepaidManufacturingExpense
727995
CY2021Q4 nhwk Prepaid Manufacturing Expense
PrepaidManufacturingExpense
563280
CY2022Q3 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
476659
CY2021Q4 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
460030
CY2022Q3 us-gaap Prepaid Insurance
PrepaidInsurance
128245
CY2021Q4 us-gaap Prepaid Insurance
PrepaidInsurance
704650
CY2022Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2430493
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2886520
CY2022Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
22983527
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3662215
CY2022Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2253010
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1503736
CY2022Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
20730517
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2158479
CY2022Q3 us-gaap Depreciation
Depreciation
442497
us-gaap Depreciation
Depreciation
749274
CY2021Q3 us-gaap Depreciation
Depreciation
115251
us-gaap Depreciation
Depreciation
292960
us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P80M
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
5067748
us-gaap Goodwill Purchase Accounting Adjustments
GoodwillPurchaseAccountingAdjustments
1600000
CY2022Q3 us-gaap Goodwill
Goodwill
3467748
CY2022Q3 nhwk Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Contract Deferred Consideration Liability
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedContractDeferredConsiderationLiability
4900000
CY2022Q3 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
9700000
CY2022Q3 nhwk Business Combination Provisional Information Initial Accounting Incomplete Adjustment Contract Deferred Consideration
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentContractDeferredConsideration
-1600000
CY2022Q3 nhwk Business Combination Provisional Information Initial Accounting Incomplete Adjustment Goodwill And Intangibles
BusinessCombinationProvisionalInformationInitialAccountingIncompleteAdjustmentGoodwillAndIntangibles
-1500000
CY2022Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1092558
CY2022Q3 nhwk Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
721923
CY2021Q4 nhwk Accrued Clinical Trial Expense Current
AccruedClinicalTrialExpenseCurrent
955013
CY2022Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
725723
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
631312
CY2022Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
313526
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
459178
CY2022Q3 nhwk Accrued Manufacturing Expenses
AccruedManufacturingExpenses
959443
CY2021Q4 nhwk Accrued Manufacturing Expenses
AccruedManufacturingExpenses
179173
CY2022Q3 nhwk Accrued Franchise Tax
AccruedFranchiseTax
10000
CY2021Q4 nhwk Accrued Franchise Tax
AccruedFranchiseTax
195000
CY2022Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
3823173
CY2021Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2419676
CY2022Q3 us-gaap Share Based Compensation
ShareBasedCompensation
700000
us-gaap Share Based Compensation
ShareBasedCompensation
2400000
CY2021Q3 us-gaap Share Based Compensation
ShareBasedCompensation
900000
us-gaap Share Based Compensation
ShareBasedCompensation
4400000
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2021Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
CY2022Q3 us-gaap Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount
EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0275
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.0215
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0251
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0067
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P5Y7M6D
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
2.25
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
4.41
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2954315
CY2021Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.62
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
204050
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
2.79
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
40375
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
12.72
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
111022
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
4.71
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3006968
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
7.34
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
42330
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y3M18D
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1580965
CY2022Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
10.00
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
42330
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P7Y7M6D
CY2022Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
3700000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y3M18D
CY2022Q3 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1500000
CY2021Q4 us-gaap Grants Receivable Noncurrent
GrantsReceivableNoncurrent
1300000
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Four
FinanceLeaseLiabilityPaymentsDueYearFour
595309
CY2022Q3 us-gaap Profit Loss
ProfitLoss
-13094771
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-7548225
us-gaap Profit Loss
ProfitLoss
-31548479
us-gaap Profit Loss
ProfitLoss
-21791941
CY2022Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-89421
CY2021Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-115505
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-265256
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-283846
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-13005350
CY2021Q3 us-gaap Net Income Loss
NetIncomeLoss
-7432720
us-gaap Net Income Loss
NetIncomeLoss
-31283223
us-gaap Net Income Loss
NetIncomeLoss
-21508095
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25613316
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25137628
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
25603481
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24828438
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.51
CY2021Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-1.22
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
CY2021Q3 nhwk Number Of Ownership Changes Over Fifty Percent
NumberOfOwnershipChangesOverFiftyPercent
5
us-gaap Operating Lease Payments
OperatingLeasePayments
200000
nhwk Leases Effective Interest Rate Percent
LeasesEffectiveInterestRatePercent
0.0665
CY2022Q3 us-gaap Operating Lease Cost
OperatingLeaseCost
195368
us-gaap Operating Lease Cost
OperatingLeaseCost
531371
CY2022Q3 us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
170492
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
296214
CY2022Q3 us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
44903
us-gaap Finance Lease Interest Expense
FinanceLeaseInterestExpense
56772
CY2022Q3 us-gaap Lease Cost
LeaseCost
215395
us-gaap Lease Cost
LeaseCost
352986
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y2M12D
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P5Y7M6D
CY2022Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M
CY2021Q3 us-gaap Finance Lease Weighted Average Remaining Lease Term1
FinanceLeaseWeightedAverageRemainingLeaseTerm1
P2Y1M6D
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0525
CY2021Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0644
CY2022Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0665
CY2021Q3 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0563
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
179752
CY2022Q3 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
245867
CY2022Q3 nhwk Lease Liability To Be Paid Remainder Of Fiscal Year
LeaseLiabilityToBePaidRemainderOfFiscalYear
425619
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
558216
CY2022Q3 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
700292
CY2022Q3 nhwk Lease Liability To Be Paid Year One
LeaseLiabilityToBePaidYearOne
1258508
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
403966
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Two
FinanceLeaseLiabilityPaymentsDueYearTwo
812383
CY2022Q3 nhwk Lease Liability To Be Paid Year Two
LeaseLiabilityToBePaidYearTwo
1216349
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
315132
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Three
FinanceLeaseLiabilityPaymentsDueYearThree
715782
CY2022Q3 nhwk Lease Liability To Be Paid Year Three
LeaseLiabilityToBePaidYearThree
1030914
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
245606
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
209214
CY2022Q3 us-gaap Finance Lease Liability Payments Due Year Five
FinanceLeaseLiabilityPaymentsDueYearFive
615269
CY2022Q3 nhwk Lease Liability To Be Paid Year Four
LeaseLiabilityToBePaidYearFour
840915
CY2022Q3 nhwk Lease Liability To Be Paid Year Five
LeaseLiabilityToBePaidYearFive
824483
CY2022Q3 us-gaap Finance Lease Liability Payments Due After Year Five
FinanceLeaseLiabilityPaymentsDueAfterYearFive
7716135
CY2022Q3 nhwk Lease Liability To Be Paid After Year Five
LeaseLiabilityToBePaidAfterYearFive
7716135
CY2022Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1911886
CY2022Q3 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
11401037
CY2022Q3 nhwk Lease Liability Payment Due
LeaseLiabilityPaymentDue
13312923
CY2022Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
188718
CY2022Q3 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
4534103
CY2022Q3 nhwk Lease Liability Undiscounted Excess Amount
LeaseLiabilityUndiscountedExcessAmount
4722821
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
1723168
CY2022Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
6866934
CY2022Q3 nhwk Lease Liability
LeaseLiability
8590102

Files In Submission

Name View Source Status
0001558370-22-017784-index-headers.html Edgar Link pending
0001558370-22-017784-index.html Edgar Link pending
0001558370-22-017784.txt Edgar Link pending
0001558370-22-017784-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
nhwk-20220930.xsd Edgar Link pending
nhwk-20220930x10q.htm Edgar Link pending
nhwk-20220930xex31d1.htm Edgar Link pending
nhwk-20220930xex31d2.htm Edgar Link pending
nhwk-20220930xex32d1.htm Edgar Link pending
nhwk-20220930xex32d2.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
nhwk-20220930x10q_htm.xml Edgar Link completed
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
nhwk-20220930_def.xml Edgar Link unprocessable
nhwk-20220930_cal.xml Edgar Link unprocessable
nhwk-20220930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
nhwk-20220930_lab.xml Edgar Link unprocessable